Investment Analysis News 7 December 2025

KSS Stock Outlook 2025: Kohl’s Turnaround Story, Latest News, Forecasts and Analysis as of December 7, 2025

Kohl’s Corporation (NYSE: KSS) has turned into one of 2025’s most unpredictable retail stocks. After a brutal start to the year and a “meme‑stock‑style” summer spike, the shares are now trading near their 52‑week highs following a surprise profit, a

7 December 2025

Company News·Financial Forecasts·Investment Analysis·Retail Industry·Stock Market

U.S. Steel (X) Stock Update: Granite City Restart, Fitch Rating and Nippon Steel’s 2026 Outlook

Published: December 7, 2025 – Informational, not investment advice. Key Takeaways Where “X stock” stands after the Nippon Steel takeover For anyone typing “X stock” into a search bar today, it’s worth starting with the blunt reality: The path to

7 December 2025

Company Updates·Investment Analysis·Stock Market News

UiPath (PATH) Stock Soars to 52‑Week High on Earnings Beat and AI Deals – Latest News, Forecasts and Analysis as of December 7, 2025

UiPath Inc. (NYSE: PATH), the enterprise automation and “agentic AI” specialist, has just staged one of the sharpest rebounds in large-cap software this year. After a blowout third quarter, a flurry of artificial intelligence partnerships, and a high‑profile collaboration with

7 December 2025

Artificial Intelligence·Earnings Reports·Financial News·Investment Analysis·Stock Market

Kroger (KR) Stock Update: Earnings Shock, E‑Commerce Pivot and Fresh Price Targets – December 7, 2025

Kroger (NYSE: KR) investors have had a lively start to December. After reporting a headline quarterly loss driven by a massive e‑commerce write‑down, the company beat profit expectations, trimmed its sales outlook and sketched an aggressive reset of its online

7 December 2025

E-Commerce·Earnings Reports·Investment Analysis·Retail Industry·Stock Market

Southwest Airlines Stock (LUV) Near 52‑Week High After Fine Waiver and Profit Cut: Outlook, Forecasts and Risks as of December 7, 2025

Ticker: LUV – Coverage date: December 7, 2025 Southwest Airlines stock is back in the spotlight. As of the close on Friday, December 5, 2025, shares of Southwest Airlines Co. (NYSE: LUV) finished just under $38, near a new 52‑week

7 December 2025

Airlines·Financial News·Investment Analysis·Risk Assessment·Stock Market

BP Stock Today: Bank of America Downgrade, $750m Buyback and Hydrogen U‑Turn — December 7, 2025 Update

BP stock is ending the first week of December in a strange but familiar place: cash is pouring out to shareholders, the share price is recovering, analysts are split, and the long‑term energy transition story is getting messier. As of

7 December 2025

Company News·Energy Industry·Financial Updates·Investment Analysis·Stock Market

Merck (MRK) Stock Outlook on December 7, 2025: Price Action, Keytruda Setback, Debt Deal and 2026 Analyst Forecasts

Updated: December 7, 2025 Merck & Co., Inc. (NYSE: MRK) — the U.S. pharmaceutical company behind blockbuster cancer drug Keytruda and HPV vaccine Gardasil — has just wrapped up a busy early-December news cycle. The company closed a multi‑billion‑dollar debt

7 December 2025

Company News·Financial Forecasts·Investment Analysis·Pharmaceuticals·Stock Market

Upstart Stock (UPST) in December 2025: Can the AI Lender Turn Explosive Growth Into Sustainable Gains?

As of 7 December 2025, Upstart Holdings (NASDAQ: UPST) sits right back in the market’s spotlight. The AI-powered consumer lender has delivered its strongest growth in years, secured multi‑billion‑dollar funding lines, and returned to GAAP profitability – yet its stock

7 December 2025

AI Technology·Financial Forecasts·Growth Stocks·Investment Analysis·Stock Market

Novo Nordisk Stock (NVO) in December 2025: Alzheimer’s Failure, GLP‑1 Price Cuts and 2026 Turnaround Hopes

Updated December 7, 2025 – for information only, not investment advice. Novo Nordisk stock today: from market darling to turnaround story Novo Nordisk (NYSE: NVO), the Danish giant behind GLP‑1 blockbusters Wegovy and Ozempic, has gone from Europe’s most valuable

7 December 2025

Financial News·Healthcare Industry·Investment Analysis·Pharmaceuticals·Stock Market

Rivian (RIVN) Stock Forecast for December 2025: Recall Fallout, AI Day Hype and Volkswagen Deal Shape the 2026 Outlook

As of the close on Friday, December 5, 2025, Rivian Automotive (NASDAQ: RIVN) stock traded around $17.95, just below a new 52‑week high of $18.17, giving the EV maker a market value of roughly $21.5 billion. MarketBeat That price is

7 December 2025

Electric Vehicles·Financial Forecasts·Investment Analysis·Stock Market·Technology News

GE Stock in December 2025: Latest News, Analyst Forecasts and Valuation After the Pullback

As of December 7, 2025, GE Aerospace (NYSE: GE) — the company that now carries the legacy General Electric ticker — is coming off a sharp rally, a strong earnings beat, and a brief earnings‑season hangover in its share price.

7 December 2025

Financial Forecasts·Investment Analysis·Stock Market

C3.ai (AI) Stock News Today: Mixed Rebound After Q2 2026 Earnings, HHS Deal and Conflicting Analyst Targets

Updated: December 7, 2025 Key Takeaways 1. How C3.ai Stock Has Traded Around December 6, 2025 C3.ai’s share price has been volatile into early December: Real‑time data as of the latest trade shows the stock around $15.08 with a market

7 December 2025

Artificial Intelligence·Earnings Reports·Financial News·Investment Analysis·Stock Market